Pune, March 20, 2023 (GLOBE NEWSWIRE) -- Xcellent Insights announces the release of the recent report "Software as a Medical Device (SaMD) Market Report 2028: A Comprehensive Assessment of Growth ...
株式会社エクサウィザーズ（東京都港区、代表取締役社長：春田 真、以下、エクサウィザーズ）は、認知症分野を対象に会話音声AIを活用したソフトウェアによるプログラム医療機器（SaMD: Software as Medical Device）の開発を開始することを発表します。会話 ...
In 2023, the MedTech custom medical software development market will continue growing with projected revenue of $579.40 billion, keeping developers busy. New solutions provide companies with the tools ...
SaMD（Software as a Medical Device）開発支援を手掛ける株式会社Save Medical（本社：東京都中央区、代表取締役社長：淺野正太郎）は、2025年9月1日より、SaMDの品質マネジメントシステム（QMS）構築を支援する手順書・様式テンプレート一式「SaMD QMS Starter Kit」の提供 ...
Researchers from Tokyo Institute of Technology highlight the diverse and emerging nature of SaMD, its growth potential, and transformative impact on healthcare services, in a new study. There has been ...
SaMD development has always operated under tension: the need for rapid iteration versus the requirement for rigorous verification, traceability, and risk control. As AI-assisted and increasingly ...
Editor’s Note: We are excited to announce that this article is the first of a series addressing Software as a Medical Device and the issues that plague digital health companies, investors, clinicians ...
As AI and machine learning have become more important for the betterment of healthcare, the introduction of software as a medical device (SaMD) tools has shown promising results for doctors and ...
On January 12, 2021, the U.S. Food and Drug Administration (FDA) published the Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan (action plan) in ...
国際規制と日本市場をつなぐSaMD開発の実務ガイド 本書は、米国Regulatory Affairs Professionals Society（RAPS）が発行した、医療機器プログラム：SaMD（Software as a Medical Device）に関する規制と開発実務ガイドの日本語訳版です。 デジタルヘルスの急拡大に伴い、新規 ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する